Iovance Therapeutics shares are trading lower after the company announced pricing of its public offering of $150 million of common stock.
Portfolio Pulse from Benzinga Newsdesk
Iovance Therapeutics has announced the pricing of its public offering of $150 million of common stock, which has led to a decrease in its share price.
July 11, 2023 | 12:35 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Iovance Therapeutics' stock price is trading lower following the announcement of its $150 million public offering of common stock.
The announcement of a public offering often leads to a decrease in the company's stock price in the short term, as it dilutes the value of existing shares. This is what is happening with Iovance Therapeutics.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100